World Health Summit – IAPO Session: Tacking Barriers to Cancer Treatment and Care
15 October 2017
10:00 to 11:30
Karl-Marx-Allee 131a 10243 Berlin
This event has now passed. To browse our upcoming events click here.
Cancer is one of the fastest growing non-communicable diseases (NCDs). A coordinated global effort between patients, the biopharmaceutical industry, government and civil society is urgently needed to address the full range of barriers to treatment and care, and increase the availability of affordable cancer care and access to essential medicines.
But with so many different barriers and needs to address, how are these multi-sectoral collaborations created and what considerations need to be taken into account for these partnerships to be impactful? True collaboration requires buy in from all stakeholders, and a decision making process that weighs a diverse set of needs and balances them with the best interests of patients.
This panel will explore the lessons learned and success factors that communities across the world need to be aware of to form partnerships that make significant progress in reducing premature deaths from NCDs. Speakers from the government, industry, NGOs, research institutions and patient advocacy organizations will participate to share their perspectives.
HRH Princess Dina Mired led the King Hussein Cancer Foundation (KHCF) in Jordan as Director General since 2002. In her capacity as Director, she founded and developed the Fundraising and Development Department at the Foundation making it one of the best fundraising institutions in Jordan.
As the mother of a cancer survivor, Princess Dina is passionate in her efforts to combat cancer. As one of the leading figures advocating early detection and screening
of breast cancer for women in Jordan, Princess Dina is the Honorary Chairperson of the Jordan Breast Cancer Program, along with President-Elect of the Union for International Cancer Control (UICC).
The Honorable Kwaku Agyeman-Manu is the Minister of Health of Ghana and Member of Parliament for Dorma Central. He was the Chairman of the Public Accounts Committee in the immediate past Parliament and holds
a Bachelor of Arts in Economics and Statistics from the University of Ghana.
He was the acting CEO of the National Health Insurance Authority in 2006, and under the government of President Kufuor, served as a Deputy Minister of State in the following Ministries: Trade and Industry, Interior, Finance, Communications, and Roads and Transport. He has served on the Boards of institutions such as the Small Arms Commission of Ghana, the Ghana Revenue Authority, Bank of Ghana, and the Divestiture Implementation Committee.
Andrew Spiegel has nearly two decades of experience in patient advocacy and co-founded the Colon Cancer Alliance (CCA), now the leading U.S.-based national patient advocacy organization dedicated to colon cancer. Spiegel, an attorney, is also a longtime board member of the Alliance and became CEO in January of 2008. He ran the CCA for nearly 5 years, before undertaking his next venture as the
co-founder and executive director of the Global Colon Cancer Association (GCCA).
Spiegel is also an active advocate for healthcare policies in the US and worldwide. He is a co-founder and currently serves on the steering committee of the Alliance for Safe Biologic Medicines (ASBM). He is on the Board of Directors, and is immediate past chair of the Digestive Disease National Coalition; is a founding member of the Coalition to Increase Clinical Trial Participation; and in May of 2016, was elected to the Board of Directors of the International Alliance of Patient Organizations (IAPO) where he chairs the fundraising committee.
Thomas B. Cueni is Director General of IFPMA since 1 February 2017. Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years he has been involved in the work of the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board.
Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist, inter alia as London correspondent for the “Basler Zeitung” and “Der Bund”, and he served as a Swiss career diplomat with postings in Paris (OECD) and Vienna (IAEA, UNIDO).
Director of the German Cancer Research Center (DKFZ) in Heidelberg, speaker of the German Cancer Consortium DKTK and founding director of the National Center for Tumor Diseases (NCT), partner site Dresden. He also holds an appointment as Professor of Radiation Oncology at the Technische Universität Dresden. Prof. Baumann has published more than 380 scholarly articles and book chapters and is Editor in Chief of the international leading green journal for radiooncology – Radiotherapy and Oncology. Prof. Baumann is founding member of the European Academy of Cancer Sciences since 2009 and has been president of the ESTRO, ECCO and of the German Society for Radiation Oncology (DEGRO). Prof. Dr. Michael Baumann has been appointed as a member of the National Academy of Science Leopoldina (2004) and received numerous academic awards.